Editorial · pages 159–162
Treatment Outcome with Weekly Cisplatin Concurrent with Radiation Therapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
Cite this article
Lone M Maqbool, Tariq R Malik, Fir Afroza, Khan N A, Muhibul Haq, Patigaroo A R. Treatment Outcome with Weekly Cisplatin Concurrent with Radiation Therapy in Locally Advanced Head and Neck Squamous Cell Carcinoma. J Int Med Sci Acad. 2012;25(3):159–162.
Opening of the article
This study was undertaken to investigate the feasibility of concurrent monochemotherapy with conventionally fractionated external beam radiotherapy and to assess its local response and acute toxicity patterns in patients with advanced locoregional head and neck squamous cell carcinoma (NHSCC). Between September 2005 and September 2007, a study involving 45 patients with stage III and IVA (AJCC-6th) HNSCC who met the eligibility criteria was undertaken. All 45 patients (median age 45 years) were given Cisplatin 40 mg/m2 weekly before radiotherapy on every Monday. Patients received radiotherapy (66-70 Grays) to the locoregional sites on Cobalt-60 unit.
Keywords
concurrent chemoradiotherapy